Intelligent Medicine Acquisition said its shareholder meeting to consider a deadline extension has been postoponed until Feb. 8. The SPAC wants to extend its deal deadline to Sept. 9. The current deadline is Thursday.
The SPAC raised $180 million in a November 2021 IPO to focus on life science companies that are using artificial intelligence, machine learning and big data to power drug discovery. Read more.
